CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: A role for the glycine site of the NMDA receptor, but not AMPA receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 1, 1999, Pages 9-15

  Mead, Andy N ^a   Stephens, David N ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; AMPA RECEPTOR; AMPHETAMINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; QUINOLONES; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032967774     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bespalov AY (1996) The expression of both amphetamine-conditioned place preference and pentylenetetrazol-conditioned place aversion is attenuated by the NMDA receptor antagonist ±-CPP. Drug Alcohol Depend 41:85-88.
2. Birch PJ, Grossman CJ and Hayes AG (1988) 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 156:177-180.
3. Burns LH, Everitt BJ, Kelley AE and Robbins TW (1994) Glutamate-dopamine interactions in the ventral striatum: Role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115:516-528.
4. Carr GD, Fibiger HC and Phillips AC (1989) Conditioned Place Preference as a Measure of Drug Reward (Cooper SJ and Liebman J eds) pp 264-319, Oxford University Press, Oxford.
5. Cervo L and Samanin R (1995) Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673:242-250.
6. B antagonists as potential therapeutic agents: Previous hopes and present reality. Amino Acids 14:235-239.
7. Goldstein JM and Litwin LC (1993) NBQX is a selective non-NMDA receptor antagonist in rat hippocampal slice. Mol Chem Neuropathol 18:145-152.
8. 3H] GABA release from cultured cortical neurons via an inhibitory action at the strychnine-insensitive glycine site. Brain Res 489:185-189.
9. Hitchcott PK and Phillips GD (1997) Amygdala and hippocampus control dissociable aspects of drug-associated conditioned rewards. Psychopharmacology 131:187-195.
10. Hoffman DC (1994) The non-competitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol Biochem Behav 47: 907-912.
11. Honoré T (1991) Inhibitors of kainate and AMPA ionophore receptors, in Excitatory Amino Acid Antagonists (Meldrum BS ed) pp 180-194, Blackwell Scientific, Oxford.
12. Kaddis FG, Uretsky NJ and Wallace LJ (1995) DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference. Brain Res 697:76-82.
13. Karler R, Calder LD and Bedingfield JB (1994) Cocaine behavioural sensitization and the excitatory amino acids. Psychopharmacology 115:305-310.
14. Karler R, Calder LD and Turkanis SA (1991) DNQX blockade of amphetamine behavioural sensitization. Brain Res 552:295-300.
15. Kessler M, Baudry M and Lynch G (1989) Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites. Brain Res 489:377-382.
16. Kim HS and Jang CG (1997) MK-801 inhibits methamphetamine-induced conditioned place preference and behavioural sensitisation to apomorphine in mice. Brain Res Bull 44:221-227.
17. Kim HS, Jang CG and Park WK (1996) Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol Biochem Behav 55:11-17.
18. Kulagowski JJ, Baker R, Curtis NR, Leeson PD, Mawer IM, Moseley AM, Ridgill MP, Rowley M, Stansfield I, Foster AC, Grimwood S, Hill RG, Kemp JA, Marshall GR, Saywell KL and Tricklebank MD (1994) 3′-(Arylmethyl)-and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally active antagonists of the glycine site on the NMDA receptor. J Med Chem 37:1402-1405.
19. Layer RT, Uretsky NJ and Wallace LJ (1993) Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res 617:267-273.
20. Leeson PD, Carling RW, Moore KW, Moseley AM, Smith JD, Stevenson G, Chan T, Baker R, Foster AC, Grimwood S, Kemp JA, Marshall GR and Hoogsteen K (1992) 4-amido-2-carboxytetrahydroquinolines: Structure-activity relationships for antagonism at the glycine site of the NMDA receptor. J Med Chem 35:1954-1968.
21. Mead AN and Stephens DN (1998) AMPA receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice. Neuropharmacology 37:1131-1138.
22. Ouardouz M and Durand J (1991) GYKI 52466 antagonizes glutamate responses but not NMDA and Kainate responses in rat abducens motoneurones. Neurosci Lett 125:5-8.
23. Pellegrini-Giampietro DE, Galli A, Alesiani M, Cherici G and Moroni F (1989) Quinoxalines interact with the glycine recognition site of NMDA receptors: Studies in guinea-pig myenteric plexus and in rat cortical membranes. Br J Pharmacol 98:1281-1286.
24. Pierce RC, Bell K, Duffy P and Kalivas PW (1996) Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1560.
25. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P and Honore T (1990) 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: A neuroprotectant for cerebral ischemia. Science (Wash DC) 247:571-574.
26. Steppuhn KG and Turski L (1993) Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. J Pharmacol Exp Ther 265:1063-1070.
27. Swedberg MDB, Jacobsen P and Honore T (1995) Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX). J Pharmacol Exp Ther 274:1113-1121.
28. Tzschentke TM and Schmidt WJ (1995) N-Methyl-D-aspartic acid receptor antagonists block morphine-induced conditioned place preference in rate. Neurosci Lett 193:37-40.
29. Tzschentke TM and Schmidt WJ (1997) Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitisation. Behav Brain Res 84:99-107.
30. Yoneda Y, Suzuki T, Ogita K and Han D (1993) Support for radiolabelingof a glycine recognition domain on the N-methyl-D-aspartate receptor ionophore complex by 5,7-[3H]dichlorokynurenate in rat brain. J Neurochem 60:634-645.